Sponsored
Sponsored
Media Summary: ... moderates a panel discussion with Gerard Marek, Your Care and Research questions answered! Hosted by: Gustavo Dziewczapolski PhD Scientific Director, Cure CMD Rachel ... DRM News streams the official 2025 Nobel Prize Lecture in Physiology or Medicine live from Stockholm. Laureates Mary Brunkow ...

Dr Alejandro Dorenbaum M D - Detailed Analysis & Overview

... moderates a panel discussion with Gerard Marek, Your Care and Research questions answered! Hosted by: Gustavo Dziewczapolski PhD Scientific Director, Cure CMD Rachel ... DRM News streams the official 2025 Nobel Prize Lecture in Physiology or Medicine live from Stockholm. Laureates Mary Brunkow ... Watch Drs. Afzali, Allegretti & Long discuss updates at : The FDA has approved donidalorsen (Dawnzera) — the first-ever RNA-targeted therapy for hereditary angioedema (HAE). In this episode, we move beyond foundational interventions and into the advanced clinical tools for lowering chronic inflammation ...

Photo Gallery

Dr. Alejandro Dorenbaum, M.D. - Chief Medical Officer, Reneo Pharmaceuticals
Mitochondrial Medicine 2021: Clinical Trials Panel 3 Discussion
UMDF Power Surge 2020: Clinical Trial Updates
Clinical Trial Update: Mavodelpar To Treat Primary Mitochondrial Myopathies (STRIDE Study)
Primary Mitochondrial Myopathy Explained
Retina World Congress 2026: New Day for DME — Expanding the Treatment Algorithm Beyond Anti-VEGF
Episode 160: Early Pathology, Biomarkers, and the Next Phase of DMD Care
2026 Ask the Expert: Dystroglycanopathies
Ebola Virus BDBV Fundamentals and Best Hope for Treatment
Nobel Laureates on The Science of T-Cells, Immune Tolerance, Potential Cures for Autoimmunity | AQ1N
Watch Drs. Afzali, Allegretti & Long discuss #IBD updates at #DDW2026: https://bit.ly/IBDChicago26-Y
FDA Approves Donidalorsen for Hereditary Angioedema | William Lumry, MD
View Detailed Profile
Dr. Alejandro Dorenbaum, M.D. - Chief Medical Officer, Reneo Pharmaceuticals

Dr. Alejandro Dorenbaum, M.D. - Chief Medical Officer, Reneo Pharmaceuticals

Dr

Mitochondrial Medicine 2021: Clinical Trials Panel 3 Discussion

Mitochondrial Medicine 2021: Clinical Trials Panel 3 Discussion

... moderates a panel discussion with Gerard Marek,

Sponsored
UMDF Power Surge 2020: Clinical Trial Updates

UMDF Power Surge 2020: Clinical Trial Updates

...

Clinical Trial Update: Mavodelpar To Treat Primary Mitochondrial Myopathies (STRIDE Study)

Clinical Trial Update: Mavodelpar To Treat Primary Mitochondrial Myopathies (STRIDE Study)

Alex Dorenbaum

Primary Mitochondrial Myopathy Explained

Primary Mitochondrial Myopathy Explained

Alex Dorenbaum

Sponsored
Retina World Congress 2026: New Day for DME — Expanding the Treatment Algorithm Beyond Anti-VEGF

Retina World Congress 2026: New Day for DME — Expanding the Treatment Algorithm Beyond Anti-VEGF

Michael Singer,

Episode 160: Early Pathology, Biomarkers, and the Next Phase of DMD Care

Episode 160: Early Pathology, Biomarkers, and the Next Phase of DMD Care

Link to episode: https://www.neurologylive.com/episode-160-early-pathology-biomarkers-next-phase-dmd-care In this Mind ...

2026 Ask the Expert: Dystroglycanopathies

2026 Ask the Expert: Dystroglycanopathies

Your Care and Research questions answered! Hosted by: Gustavo Dziewczapolski PhD Scientific Director, Cure CMD Rachel ...

Ebola Virus BDBV Fundamentals and Best Hope for Treatment

Ebola Virus BDBV Fundamentals and Best Hope for Treatment

Roger Seheult,

Nobel Laureates on The Science of T-Cells, Immune Tolerance, Potential Cures for Autoimmunity | AQ1N

Nobel Laureates on The Science of T-Cells, Immune Tolerance, Potential Cures for Autoimmunity | AQ1N

DRM News streams the official 2025 Nobel Prize Lecture in Physiology or Medicine live from Stockholm. Laureates Mary Brunkow ...

Watch Drs. Afzali, Allegretti & Long discuss #IBD updates at #DDW2026: https://bit.ly/IBDChicago26-Y

Watch Drs. Afzali, Allegretti & Long discuss #IBD updates at #DDW2026: https://bit.ly/IBDChicago26-Y

Watch Drs. Afzali, Allegretti & Long discuss #IBD updates at #DDW2026: https://bit.ly/IBDChicago26-Y

FDA Approves Donidalorsen for Hereditary Angioedema | William Lumry, MD

FDA Approves Donidalorsen for Hereditary Angioedema | William Lumry, MD

The FDA has approved donidalorsen (Dawnzera) — the first-ever RNA-targeted therapy for hereditary angioedema (HAE).

Advanced Therapies to Lower Systemic Inflammation | Dr. Adam Sewell, MD

Advanced Therapies to Lower Systemic Inflammation | Dr. Adam Sewell, MD

In this episode, we move beyond foundational interventions and into the advanced clinical tools for lowering chronic inflammation ...

Keynote Session

Keynote Session

Matthew Harms,

Related Video Content

Dermatology & Medical Aesthetics in Stratham, NH | Optima information

Optima Dermatology is now open in Stratham, NH and offers a full scope of medical, surgical, and cosmetic dermatology...

Dr. Heath Meattey, MD, Endocrinologist | Stratham, NH | WebMD information

Dr. Heath Meattey specializes in endocrinology, diabetes, and metabolism, with additional expertise in internal...

Primary Care in Stratham, NH | Seacoast Direct Primary Care information

At Seacoast Direct Primary Care, we act as your advocate, ensuring seamless coordination of care. From specialist...

Gavin Little, DO - Core Physicians information

Dr. Gavin Little is a Primary Care Provider (PCP) board certified in Internal Medicine in Stratham, NH who cares for...

Dr. James Henry Dolan - Podiatry, Stratham NH - HealthCare4PPL information

Detailed profile of James Henry Dolan, a Podiatry specialist in Stratham NH, providing phone numbers, practice...

Sponsored